Medical Devices

The organ transplant innovator's massive Q4 profit came from a tax rule, but it signals a major turning point and confidence in long-term profitability.

Treace Medical reports a Q4 revenue dip despite surgeon growth, revealing a strategic shift to lower-priced kits and a challenging 2026 outlook.

A new oral therapy, mavorixafor, receives a key recommendation in Europe, offering a beacon of hope for patients with a debilitating ultra-rare immune disorder.

After a 25-year era of global growth, Lansinoh appoints Julie Talbot to redefine parental support and scale a new, empathetic vision worldwide.

Medit's new initiative links scanner purchases to children's dental care, sparking a conversation on corporate responsibility in the dental tech industry.

Tectonic Therapeutic reports key clinical progress in two distinct rare diseases, backed by a strong cash position and new leadership for its next phase.

Neurizon Therapeutics has started dosing its promising ALS drug, NUZ-001, in the groundbreaking HEALEY Platform Trial, a pivotal step for patients.

The 3M spin-off navigates a transformative year, posting strong organic growth driven by MedSurg and Dental, despite a reported sales dip from divestitures.

A new study shows alternating magnetic fields can destroy antibiotic-resistant biofilms on medical implants, offering hope for a non-surgical treatment.

With TGA approval, Optellum's AI platform arrives to help tackle Australia's low lung cancer survival rates by enabling earlier, more accurate detection.

With $13M in new funding, BrainCheck is expanding its AI platform to help doctors detect dementia earlier and manage cognitive care at scale.

GEMMABio has dosed the first infant in a trial for its next-gen SMA1 gene therapy, a new approach designed to improve safety and global access.

A new $3M endowed professorship at UMSOM, funded by state and private partners, aims to accelerate medical innovation by bridging engineering and medicine.

Beyond software, an Upstate NY incubator is tackling global challenges in health, climate, and ag-tech, turning physical ideas into world-changing products.

With the hire of Greg Crescenzi, the famed academic repository signals a major strategic expansion to bridge the gap between scientific sharing and drug development.

Calyxo's CVAC System shows a dramatic reduction in repeat procedures and costs, but recent safety warnings add complexity to its widespread adoption.

Heron Therapeutics posts record growth fueled by ZYNRELEF and APONVIE, issuing strong 2026 guidance and signaling a successful pivot to profitability.

Sensus Healthcare's new Sensus Link software aims to upgrade existing skin cancer treatment systems, signaling a major strategic shift to the cloud.

Spectral Medical shifts its FDA submission for a breakthrough sepsis device, a strategic move that could strengthen its case but delays a potential lifeline.

With promising data for its oral STAT6 degrader and a cash runway into 2029, Kymera Therapeutics is poised to disrupt the injectable-dominated market.